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Abstract
Background: It is thought that spasticity has an influence on the development of functional motor
abilities among children with cerebral palsy (CP). The extent to which spasticity is associated with
the change in motor abilities in young children with CP has not been established. The objective of
this study is to evaluate the relationship of initial spasticity in young children with CP and their gross
motor function development over one year.
Methods: Fifty children with CP aged 18 months, GMFCS-levels I-V participated in a longitudinal
observational study. Change in gross motor functioning (GMFM-66) was measured over one year.
The level of spasticity measured at the first assessment was determined with the Modified Tardieu
Scale in three muscle groups of the lower extremity (adductor muscles, the hamstrings and the m.
gastrocnemius). The Spasticity Total Score per child was calculated with a maximum score of 12
points.
Results: Spearman's Rho Correlation (-0.28) revealed a statistically significant relationship (p <
0.05) of small strength between the Spasticity Total Score and the change score of the GMFM-66.
Conclusion: Our findings indicate that when measured over one year, spasticity is marginally
related to gross motor function development in infants with CP. The initial level of spasticity is only
one of the many child, environmental and family factors that determines gross motor development
of a young child with CP.
Background
Cerebral palsy (CP) describes a group of permanent disor-
ders, effecting the development of movement and pos-
ture, causing activity limitation, that are attributed to non-
progressive disturbances that occurred in the developing
fetal or infant brain [1]. The motor disorders of CP are
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often accompanied by disturbances in sensation, percep-
tion, cognition, communication, and behaviour, as well
as epilepsy and secondary musculoskeletal problems [1].
Motor impairment in CP can be classified into three dif-
ferent subtypes, i.e. spastic, dyskinetic or the ataxic form
[2]. The most common movement disorder in CP is spas-
tic paresis, defined as a posture and movement dependent
tone regulation disorder [3]. A broad diversity of muscle
function impairments can be present in spastic paresis.
Clinical symptoms of impaired muscle function can either
be related to an impairment of muscle activation, leading
to both deficit (or negative) symptoms (e.g. paresis, loss
of voluntary selective motor control) and excess (or posi-
tive) symptoms (e.g. spasticity), or to a change in biome-
chanical properties of muscles and connective tissues [4].
The most prominent symptom in spastic paresis is spastic-
ity. According to a generally accepted and quoted defini-
tion of spasticity in both adult and paediatric literature,
spasticity is defined as 'a motor disorder characterized by
a velocity dependent increase in tonic stretch reflexes
(muscle tone) with exaggerated tendon jerks, resulting
from hyper-excitability of the stretch reflex, as one compo-
nent of the upper motor neuron syndrome' [5,6]. Others,
e.g. members of the SPASM consortium, have tried to
redefine spasticity to encompass the current understand-
ing of pathophysiology and clinical practice [6]. There is a
need for evidence that this wider definition is useful and
that measures of spasticity are congruent with the defini-
tion [6]. In clinical practice, spasticity is assessed as a
velocity-dependent increased resistance to passive muscle
stretch.
Despite limited knowledge about the relationship
between spasticity and motor abilities, many intervention
strategies focus on reduction of spasticity, with the
assumption that reduction of spasticity will lead to an
increase in motor abilities. There is limited evidence how-
ever, that reduction of spasticity in children with CP is
related to a better development [7]. Therefore, knowledge
of the nature and strength of relationships between the
initial impairments in movement, posture and (change
in) performance in a child with CP is very important to
serve as a base for rehabilitation interventions. Recent
cross-sectional studies in children with CP have shown a
modest, negative relationship between spasticity and
daily activities in children with CP aged three years and
older [8-10]. Also in one botulinum toxin type A (BoNT-
A) intervention study in 35 children (mean age 5 years) it
was found that at baseline spasticity was poorly related to
the 66-item version of the Gross Motor Function Measure
(GMFM-66) for the gastrocnemius muscles (r < 0.35) and
moderately related to the GMFM-66 for the hamstrings (r
= -0.55). Moreover, change score correlations between
spasticity and GMFM-66-score at each of 2 months and 6
months was no more than fair (i.e. maximum r < 0.40)
[11]. In conclusion, spasticity - as a primary impairment
in CP - is thought to have an influence on the develop-
ment of the functional motor abilities, but the extent to
which spasticity is related with the change in motor abili-
ties in infants with CP has not been established in a study
with a longitudinal design.
The aim of this study is to evaluate the relationship
between initial spasticity in the lower limbs of young chil-
dren (under the age of two years) with CP and the devel-
opment of their gross motor function over one year. Based
on the evidence in the literature we hypothesize that first,
spasticity early in life has a negative relationship with
gross motor development. Second, the strength of the cor-
relation between initial spasticity and gross motor devel-
opment is modest, accounting for no more than 16% of
explained variation in the change score of the 66-item ver-
sion of the Gross Motor Function Measure (GMFM-66).
Methods
The present study is part of the PERRIN CP 0-5 study,
which, in turn, is part of a longitudinal research program
entitled Pediatric Rehabilitation Research in the Nether-
lands (PERRIN). In the PERRIN program, the course and
determinants of the functional status of children and ado-
lescents with CP are studied http://www.perrin.nl. The
focus in PERRIN CP 0-5 is on the development of activi-
ties and participation of young children with CP starting
at age 18 months. The protocol has been approved by the
Ethics Committee of the University Medical Center
Utrecht and by other participating rehabilitation centres
and hospitals in the Netherlands (see acknowledge-
ments).
Parents were asked by the paediatrician, child neurologist
or rehabilitation physician of their child whether they
were willing to participate in the PERRIN CP 0-5 study.
Between April 2003 and December 2006, 77 children
under two years of age, corrected age if applicable, were
eligible for the present study. Written consent was
obtained from 63 mothers and fathers (82% response
rate). The diagnosis of CP was evaluated and, in the case
of uncertainty checked by an independent neurologist.
Children who had additional disorders (besides CP)
which had an important and persistent influence on the
motor abilities (e.g. Spina Bifida, cardiac impairments,
severe bronchopulmonal dysplasia) and parents with
insufficient knowledge of the Dutch language which
could hamper assessments, were excluded from the study.
For the current study, complete data on the GMFM and
spasticity were available in 50 out of 63 children at 18
months of age participating in the PERRIN CP 0-5 study.
The group of participants consisted of children with aBMC Musculoskeletal Disorders 2009, 10:108 http://www.biomedcentral.com/1471-2474/10/108
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variety in type of the predominant motor disorder, the
numbers of limbs involved (uni- versus bilateral involve-
ment according to SCPE guidelines) [2] and the level of
gross motor abilities, classified according to the GMFCS
(Gross Motor Function Classification System) [12]. For
this study we used the GMFCS descriptions provided for
children aged 2 to 4 years at time 2 as being a more precise
classification than the classification for infants under 2
years of age [13]. GMFCS Level I represents the highest
level of functional abilities and GMFCS Level V the low-
est. The baseline characteristics of participants are pre-
sented in Table 1.
Procedure
Gross motor function was assessed at the age of 18
months (t1) and one year later (t2). Initial spasticity was
assessed at t1. All assessments were performed according
to the study protocol by a team of trained research assist-
ants with a background in physiotherapy, movement sci-
ences or medicine. To monitor the reliability of the




Gross motor function of all children was assessed using
the Gross Motor Function Measure-66 (GMFM-66) [14].
The GMFM-88 is a standard criterion-referenced measure
for detecting and monitoring changes in motor functions
[15]. The 88 items of the test assess activities in five
dimensions. Each item is scored using a 4-point Likert
scale (0-3 with 0 representing the lowest performance
level and 3 the highest). The GMFM-66 uses 66 of the 88
items and was developed using Rasch analysis to improve
the sensitivity and interpretability of the test [14]. For each
child the values of the GMFM-88 were analyzed using the
Gross Motor Ability Estimator computing scoring pro-
gram to acquire an interval-level GMFM-66 score ranging
from 0 to 100 (maximum score) which represents a
child's overall level of gross motor functions [14,15]. The
GMFM-66 is a valid and reliable measure [15] with
responsiveness to change [16].
To evaluate the development of gross motor function in
one year, the interval-level GMFM-66 scores of the first
measurement moment (t1) were deducted from the
GMFM-66 scores of the second measurement moment
(t2). The result of this deduction was called the GMFM-66
Change Score and reflects the change in GMFM-66 score
in one year (i.e. the progression or regression of gross
motor functioning in one year).
Spasticity
Spasticity of the muscle groups that are most relevant for
gross motor function of the lower extremities (adductor
muscles, the hamstrings and the m. gastrocnemius) were
assessed with the Modified Tardieu Scale (MTS) [17],
which is a modification of the Tardieu scale [18]. The MTS
grades spasticity by measuring the joint angle of the ROM
at which an increase in muscle tone ('catch') is encoun-
tered at a high velocity (< 1 sec) passive stretch (R1).
Acceptable inter-rater reliability of the MTS has been
reported in two studies in children with CP [11,19]. In a
third study, however, the intra-class correlation coefficient
of the MTS in children with spastic CP did not reach the
acceptable limit of good reliability [20].
Because the impact on motor function of spasticity is not
the same for the different muscle groups that were
assessed, a rough ordinal scale (with 3 different levels) of
spasticity was created. This scale was created on the opin-
ion of five experts in the field of spasticity in children with
CP (a rehabilitation physician, two physical therapists
and two rehabilitation researchers) and the available
information about the variance in assessing spasticity
with the MTS [19]. The first level of the spasticity scale (no
spasticity, level 0) was determined by the measurement
error per muscle group in the literature, our own data and







Spastic bilateral 27 (54)
Spastic unilateral right 11 (22)
Spastic unilateral left 11 (22)
Dyskinetic 1 (2)
GMFCS level
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expert opinion. Fosang et al. found an inter-rater variance
of approximately 10 degrees in measuring the adductor
muscles at a high velocity passive stretch, 20 degrees in
measuring the hamstrings and 15 degrees in measuring
the gastrocnemius muscle in children with CP (age range
2 years 4 months to 10 years)[19] The inter-rater differ-
ence was calculated from data gathered in order to deter-
mine the 'measurement error' in the study's
measurements. This measurement error corresponded
with the measurement error that was the result of the
expert opinion round. The expert panel considered a
measurement error of 0-10° for the adductors and gas-
trocnemius and 0-20° for the hamstrings as an acceptable
clinical cut-off point. To specify the second level of spas-
ticity (probable spasticity, level 1) in a spasticity scale, the
collected data of the three muscle groups (left and right)
of the included participants were statistically analyzed for
mean, range and standard deviation. Of each separate
muscle group 1 standard deviation (SD) corresponded
with the 'middle' range of spasticity as indicated by the
expert-panel, and values more than 1 SD corresponded
with the definite presence of spasticity (level 2). In sum-
mary, based on the aforementioned procedure an ordinal
spasticity scale with three levels of spasticity was devel-
oped (Table 2).
Furthermore, the spasticity-scale was slightly adjusted
based on the group of participants, who are children with
CP in the age 1.5 years (Table 3). For example the adduc-
tor muscles: according to Fosang et al[19], the measure-
ment error was 0-10 degrees. The standard full range of
motion of the adductor muscles is 70 degrees. However,
in this study participant's largest abduction angle (ROM
of the adductor muscles) measured was 90 degrees. There-
fore, the range of error of measurement ('level 0') was
adjusted to a range of 90-60 degrees. The middle range of
spasticity in the adductors was 10 degrees (1SD). The mid-
dle range ('level 1') of the classification was 60-51 degrees,
and 'level 2' was valued as 50 degrees or less.
Finally, the angles of spasticity in degrees (R1) were clas-
sified according to these three levels. Adding these levels
for all muscle groups (right and left side) resulted in a
maximal score of 12 points. The total value of spasticity
per child was named Spasticity Total Score.
Statistical analysis
Statistical analysis of data was carried out using SPSS-16
(SPSS, Chicago, Illinois, USA). The relationship between
the Spasticity Total Score and the GMFM-66 Change Score
was expressed by Spearman's Rho. The data were analyzed
for the total group (n = 50). We refrained from undertak-
Table 2: Classification of spasticity
Level of spasticity Score Cut-off points for R1 (in degrees per muscle group) Range(°)
ADDUCTORS
No spasticity 0 0-10
Probable spasticity 1 11-20 1 SD (Right:10.0 Left:10.1)
Definite spasticity 2 21 >
HAMSTRINGS
No spasticity 0 0-20
Probable spasticity 1 21-40 1 SD (Right: 17.7, Left: 18.0)
Definite spasticity 2 41 >
GASTROCNEMIUS
No spasticity 0 0-10
Probable spasticity 1 11-25 1 SD (Right 13.4, Left 13.0)
Definite spasticity 2 26 >
Classification with 3 different levels of spasticity per muscle group based on the measurement error per muscle group in the literature (Fosang et al. 
[19]) and expert opinion.BMC Musculoskeletal Disorders 2009, 10:108 http://www.biomedcentral.com/1471-2474/10/108
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ing additional subgroup analysis because of the difficulty
to classify the type of motor disorder and its distribution
in children with CP under the age of 2 years accurately.
For interpreting the values of the strength of the correla-
tion the guidelines of Cohen [21] were used. A Spear-
man's Rho of 0.10 to 0.29 counts as a small, a Rho of 0.30
to 0.49 as a medium and a Rho of 0.50 to 1.00 as a large
correlation. The Spearman's Rho square indicates how
much variation of the GMFM-66 Change Score was
explained by the ordinal Spasticity Total Score.
Results
According to the Spasticity Total Score we used, 17 of the
50 children did not have spasticity at their first assess-
ment. One of these 17 children was classified as dominant
dyskinetic movement disorder, five as spastic CP with
bilateral involvement and 11 as spastic CP with unilateral
involvement.
The relationship between initial spasticity (Spasticity
Total Score) and the GMFM-66 development in one year
(GMFM-66 Change Score) is reflected in Figure 1. Spear-
man's Rho correlation (-0.28) revealed a statistically sig-
nificant (p < 0.05) relationship of small strength between
the assessed total spasticity and the Change Score of the
GMFM 66. The square Spearman's Rho was 0.08.
Discussion
In the group of children with CP included in this study,
the data gathered indicates that there is a statistically sig-
nificant relationship between spasticity at the age 18
months and gross motor development over one year.
Only 8% of the variance in change in motor function
could be explained by spasticity as primary impairment.
As shown in Figure 1, the change in motor score in the
absence of spasticity (total spasticity score = 0) could vary
between a 24 point increase (a child with unilateral spas-
tic CP, GMFCS level I) to a decrease of almost 4 points (a
child with bilateral spastic CP, GMFCS level V), while a
child with severe spasticity in all three muscle groups
(total spasticity score = 12, GMFCS level III) had an
increase of 8 points in GMFM-score in one year. Both of
our hypothesis in this study were confirmed. This study
reveals that spasticity early in life is a minimal factor in
functional change when considered alone and would be
probably less when other child, environment and family
factors are included.
In general, assessment of spasticity is difficult. Valid and
reliable assessment of spasticity in young children is even
more a challenge, and the most common spasticity scales
should be interpreted with caution [22,23]. The Ashworth
scale (AS), Modified Ashworth Scale (MAS), Tardieu scale
Table 3: Classification of spasticity applied to the obtained data in this study.
Level of spasticity Score Cut-off points for the angle of spasticity 
(R1) in our group (in degrees per muscle group)
Range
ADDUCTORS Abduction
No spasticity 0 61.>
Probable spasticity 1 60-51 1 SD (Right:10.0 Left:10.1)
Definite spasticity 2 ≤ 50
HAMSTRINGS Popliteal angle
No spasticity 0 0-20
Probable spasticity 1 21-40 1 SD (Right: 17.7, Left: 18.0)
Definite spasticity 2 ≥ 41
GASTROCNEMIUS Ankle-foot position
No spasticity 0 11 - 50 dorsiflexion
Probable spasticity 1 10 dorsiflexion - (-5)plantarflexion 1 SD (Right 13.4, Left: 13.0)
Definite spasticity 2 ≤ (-5) plantarflexion
Data based on spasticity (R1 angle) per muscle group from young children with cerebral palsy.BMC Musculoskeletal Disorders 2009, 10:108 http://www.biomedcentral.com/1471-2474/10/108
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and Modified Tardieu Scale are the most reported meas-
ures in children with CP. According to the review by
Scholtes et al. [23] the original Tardieu Scale is the only
suitable instrument to measure spasticity because it meas-
ures a velocity dependent resistance at three specified
velocities. This method is very time consuming and would
interfere with the feasibility of using this instrument in
young children.
A limitation of the current study is that it was not possible
to study the inter-rater reliability of the Modified Tardieu
Scale as the assessment was part of a larger comprehensive
assessment in young children within the PERRIN CP 0-5
study. Moreover, the assessments have been performed by
a team of investigators with different backgrounds and
levels of experience, which may result in a higher variance
in measurements than in the study of Kilgour et al. [24].
When assessing spasticity with the Modified Tardieu
Scale, Fosang et al. [19] found inter-rater differences of
approximately 10 degrees for the adductors, 20 degrees
for the hamstrings and 10-15 degrees for the gastrocne-
mius muscle. These reliability findings are similar with
our assessors. Furthermore, with the measurement error
taken into account by the recoding of the obtained R1
angles for each muscle group to the spasticity score, it was
felt that inter-rater measurement errors - if any - were
taken into account for this population. For the study our
own composite spasticity score based on the MTS was
developed. As a consequence, we do not have data on the
reliability of the Spasticity Total Score in young children
with CP. A few studies have been published in which clas-
sification of spasticity with the Modified Ashworth Scale
has been given in adult stroke patients [25,26]. By adjust-
ing the MAS to a 0-5 scale and applying this scale to the
affected flexors at the elbow, wrists and fingers a "Com-
posite Spasticity Index' from 0-15 was made. Ibrahim and
Hawamdeh [27] used the same 'Composite Spasticity
Index' as created by Francis et al. [25] in a group of chil-
dren with CP. The 0-5 scale was applied to the spastic hip
adductors and the spastic knee extensors. Despite its fre-
quent use in clinical practice, the validity and the reliabil-
ity of the MAS as a measure of spasticity, however, is
questioned [22].
The results of this study are in line with other studies on
the modest relationship between spasticity (ICF body
function level) and capabilities/performance (ICF activi-
ties and participation level) in other pediatric popula-
tions[8-11] The strengths of this study are the young age
of children with CP (starting under two years of age), a
Observed relationship between spasticity and gross motor function development Figure 1
Observed relationship between spasticity and gross motor function development. Initial Spasticity Total Score 
(minimal score: 0, maximum score: 12) per child (age 18 months) and the change in GMFM 66 score in one year (n = 50). 
Spearman's Rho Correlation is -0.28 (p = 0.05); Square Spearman's Rho = 0.08. Approximately 8% of the GMFM change score 
is explained by the Spasticity Total Score.BMC Musculoskeletal Disorders 2009, 10:108 http://www.biomedcentral.com/1471-2474/10/108
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valid instrument with acceptable inter-rater reliability for
assessing spasticity (MTS) and a valid and reliable instru-
ment for assessing change in gross motor abilities
(GMGM-66). All data collected are from a large clinical
based sample of young children diagnosed as having CP,
who were receiving a range of accepted medical physical
therapy and rehabilitation services. It is believed the sam-
ple is representative of the population of young children
with CP in The Netherlands, with results able to be gener-
alized to populations in the same age group elsewhere
receiving similar types of mixed developmental therapies.
The small square Spearman's Rho for all CP subtypes
combined indicates that there seems to be more variables
determining the development of the gross motor function
over one year than spasticity alone. The overall relation-
ship between spasticity and gross motor development
may have been overestimated since 22 children with uni-
lateral spastic CP and their data from both lower extremi-
ties were included in the analysis. However, the Spasticity
Total Score in children with unilateral CP ranged from 0
to 4 indicating that the presumed unaffected side is really
not unaffected in these children. The association between
spasticity and gross motor function would probably be
even less when the analysis included other possible child
characteristics such as deficit symptoms (muscle weakness
[10], loss of voluntary selective motor control), distur-
bances of sensation, perception, and cognition. Further-
more, if secondary musculoskeletal impairments occur,
these factors also can have an influence on the develop-
ment of gross motor function. Bartlett and Palisano intro-
duced a multivariate model of determinants of motor
change for children with CP, based on literature and
expert opinion (Figure 2) [28]. In this model possible
determinants of motor change include secondary impair-
ments, personal and contextual factors (family ecology)
and interventions. Since the presence and severity of con-
tractures are limited in children aged 1 year of age, it is felt
that secondary impairments are of minor influence on the
results.
The results do not imply that reducing spasticity in a child
with CP can not be beneficial in the attainment of gross
motor skills or in the prevention of secondary impair-
ments that could negatively influence the level of motor
abilities. Spasticity treatment with botulinum toxin in
combination with intensive physical therapy has been
shown to be effective, not only in reducing spasticity in
Model of determinants of motor change for children with cerebral palsy Figure 2
Model of determinants of motor change for children with cerebral palsy. Solid lines and ovals are part of the pro-
posed model; dotted lines and ovals represent parts of an expanded model as proposed by Bartlett and Palisano.11 (With per-
mission of Physical Therapy).BMC Musculoskeletal Disorders 2009, 10:108 http://www.biomedcentral.com/1471-2474/10/108
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the short term, but also in promoting improvement in
motor abilities as measured with the GMFM in both
young and older children [29]. The study looked at the
relationship between initial spasticity and gross motor
development occurring over one year in young children
with CP under two years of age. A recent study indicates
that in children with CP the muscle tone in the gastrocne-
mius muscle increases significantly from 1 to 4 years of
age [30]. To look at the role of spasticity and its relation-
ship with the development of gross motor function and
contractures in the long-term these children should be fol-
lowed longitudinally for a longer period of time.
Conclusion
In conclusion, the findings indicate that spasticity is mar-
ginally related to the development of gross motor func-
tion in one year in children with CP under the age of two.
Knowledge about determinants of gross motor perform-
ance may be useful to set realistic rehabilitation goals and
provide both patients and parents complete and reliable
information about the expected effects of spasticity treat-
ment.
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